Sumitomo Pharma Co., Ltd. (FRA:DPM)

Germany flag Germany · Delayed Price · Currency is EUR
15.20
+0.50 (3.40%)
At close: Nov 28, 2025
313.04%
Market Cap5.66B
Revenue (ttm)2.56B
Net Income (ttm)891.08M
Shares Outn/a
EPS (ttm)2.24
PE Ratio6.35
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,500
Average Volume201
Open14.90
Previous Close14.70
Day's Range14.90 - 15.20
52-Week Range3.00 - 15.20
Betan/a
RSI71.40
Earnings DateJan 30, 2026

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. engages in manufacture, purchase, and sale of pharmaceutical products for medical treatment in Japan, North America, and Asia. The company offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. It also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, the company offers veterinary drugs, medical devices, etc. It h... [Read more]

Industry Pharmaceutical Preparations
Founded 1897
Employees 3,832
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol DPM
Full Company Profile

Financial Performance

Financial numbers in JPY Financial Statements

News

There is no news available yet.